Exclusive Articles 1 min.Read Healthcare Disruption – Will Ola, Swiggy, Pharmaeasy, and Hospitals Converge to Deliver Health Care on Call at Your Doorstep? By Anup Soans May 26, 2022 FacebookTwitterPinterestWhatsApp Swiggy is working on a marketplace to onboard local stores and direct-to-consumer (D2C) brands and the pilot is already underway. The platform is called Minis. There are select brands and merchants with whom Swiggy is testing this out. Free Membership Required You must be a Free member to access this content. Join Now Already a member? Log in here Hot this week MedicinMan Market Intelligence Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros? October 20, 2026 0 Private capital is transforming India's healthcare landscape. But is... Healthcare C-Suite Movements Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery October 18, 2026 0 Anuj Pasrija has been elevated to Country Lead, Johnson... MedicinMan Market Intelligence China’s Biopharma Strategy: A Warning and Opportunity for India October 17, 2026 0 China is playing a long game in biopharma. And... Healthcare C-Suite Movements Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences. October 14, 2026 0 With over two decades of experience across finance, strategy,... MedicinMan Market Intelligence Who Is Accountable for the Medicine in Your Hand? October 11, 2026 0 The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes... Topics MedicinMan Market Intelligence Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros? 0 Private capital is transforming India's healthcare landscape. But is... Healthcare C-Suite Movements Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery 0 Anuj Pasrija has been elevated to Country Lead, Johnson... MedicinMan Market Intelligence China’s Biopharma Strategy: A Warning and Opportunity for India 0 China is playing a long game in biopharma. And... Healthcare C-Suite Movements Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences. 0 With over two decades of experience across finance, strategy,... MedicinMan Market Intelligence Who Is Accountable for the Medicine in Your Hand? 0 The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes... MedicinMan Market Intelligence Who Profits From Trust? 0 Indian healthcare does not suffer from a shortage of... MedicinMan Market Intelligence The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital? 0 The next owner of an Indian hospital may not... MedicinMan Market Intelligence Indian Pharma’s Three Deficits—and Three Potential Dividends 0 Indian pharma has already done the hard thing once. It... Related Articles Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology? Exclusive Articles August 21, 2026 The Anatomy of a Miscalculation: Why Maharashtra’s Homeopathic Prescription Policy Defies Global Medical Standards Exclusive Articles August 10, 2026 What ChrysCapital’s Takeover Of Novartis India Really Means Exclusive Articles July 30, 2026 Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare AI in Healthcare July 17, 2026 Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman Exclusive Articles June 8, 2026 Previous articleHuman Library – Reading People Through Their Life’s ExperiencesNext articleDigital in Pharma and RoI – What and How to Measure Metrics that Matter